STX1B — Syntaxin-1B
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">STX1B — Syntaxin-1B</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>STX1B</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Syntaxin-1B</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16p11.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[11275](https://www.ncbi.nlm.nih.gov/gene/11275)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[616715](https://www.omim.org/entry/616715)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000199330</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P61264](https://www.uniprot.org/uniprot/P61264)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, epilepsy, ataxia</td>
</tr>
</table>
Stx1B — Syntaxin 1B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: STX1B — Syntaxin-1B
.infobox.infobox-gene
Overview
Syntaxin-1B is a t-SNARE protein that plays a critical role in neurotransmitter release by forming SNARE complexes with SNAP-25 and VAMP2. It is essential for synaptic vesicle docking and fusion at the presynaptic membrane. STX1B is expressed throughout the brain, particularly in the hippocampus, [cortex](/brain-regions/cortex), and cerebellum. Mutations in STX1B are associated with epilepsy and ataxia, and altered syntaxin-1B expression has been reported in Alzheimer's disease brains.
Protein Structure
Syntaxin-1B is a 288-amino acid protein belonging to the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) family. The protein consists of several distinct domains:
- N-terminal Domain (Habc domain): This regulatory domain folds back onto the SNARE motif in an autoinhibitory conformation, regulating the protein's availability for SNARE complex formation[@rizo2018].
- SNARE Motif: A central coiled-coil domain of approximately 60 residues that participates in the formation of the ternary SNARE complex with SNAP-25 and VAMP2[@sutton2018].
- Transmembrane Anchor: A C-terminal transmembrane domain that anchors Syntaxin-1B to the presynaptic plasma membrane[@galli2016].
The structure of Syntaxin-1B allows it to function as a molecular zipper, bringing together the synaptic vesicle membrane (via VAMP2) and the presynaptic plasma membrane (via Syntaxin-1B and SNAP-25) to facilitate membrane fusion and neurotransmitter release.
SNARE Complex and Synaptic Transmission
The SNARE complex is the core machinery for synaptic vesicle fusion. Syntaxin-1B forms a stable ternary complex with:
- SNAP-25: A presynaptic protein that provides two α-helices to the SNARE complex
- VAMP2 (Synaptobrevin-2): A vesicle-associated protein that initiates complex formation
The assembly of the SNARE complex proceeds through a stepwise process:
VAMP2 binding: Synaptobrevin/VAMP2 on the synaptic vesicle initiates complex formation
SNAP-25 recruitment: SNAP-25 provides additional helices to stabilize the complex
Syntaxin-1B incorporation: Syntaxin-1B completes the four-helix bundle
Zippering: The complex zippers from N-terminus to C-terminus, pulling the membranes together
Fusion: The energy released from zippering drives membrane fusion[@jahn2016]This process is tightly regulated by multiple proteins including Munc13, Munc18, RIM, and complexins, which ensure precise timing and location of neurotransmitter release.
Normal Function
The STX1B gene encodes the Syntaxin-1B, a protein involved in [synaptic function](/mechanisms/synaptic-dysfunction-pathway), [axonal transport](/mechanisms/axonal-transport), and neuronal signaling. This protein plays critical roles in maintaining neuronal health and function through its involvement in intracellular trafficking and signal transduction pathways.
Beyond its role in neurotransmitter release, Syntaxin-1B is also involved in:
- Synaptic vesicle pool maintenance: Regulating the availability of vesicles for release
- Presynaptic plasticity: Modulating short-term and long-term synaptic plasticity
- Neuronal excitability: Influencing calcium entry through voltage-gated calcium channels
- Intracellular trafficking: Facilitating protein transport within [neurons](/entities/neurons)
Disease Associations
Dysfunction or altered expression of STX1B has been associated with several neurodegenerative diseases:
Alzheimer's Disease (AD)
Altered expression and function of STX1B has been reported in AD brains, contributing to synaptic dysfunction and axonal transport deficits[@bai2018]. Key mechanisms include:
- Synaptic loss: Reduced Syntaxin-1B levels correlate with cognitive decline
- Amyloid-β toxicity: [Aβ](/proteins/amyloid-beta) oligomers impair SNARE complex formation
- [Tau](/proteins/tau) pathology: Hyperphosphorylated [tau](/proteins/tau) disrupts Syntaxin-1B trafficking
- Calcium dysregulation: Altered Syntaxin-1B affects calcium channel function
Parkinson's Disease (PD)
STX1B protein is involved in intracellular transport pathways that are disrupted in PD:
- Synaptic dysfunction: Loss of dopaminergic nerve terminals
- Axonal transport defects: Impaired vesicle trafficking
- [Alpha-synuclein](/proteins/alpha-synuclein) connection: Potential interactions with α-synuclein aggregates
Epilepsy and Ataxia
Mutations in STX1B are directly linked to epileptic disorders and cerebellar ataxia:
- Loss of function: Mutations impair SNARE complex assembly
- Dysregulated release: Abnormal neurotransmitter release patterns
- Cerebellar dysfunction: Impaired Purkinje cell function
Expression Pattern
STX1B is expressed in various brain regions, with high expression in:
- [Hippocampus](/brain-regions/hippocampus) — particularly CA1 and dentate gyrus
- Cerebral cortex — layers 2/3 and layer 5 pyramidal neurons
- Cerebellum — Purkinje cells and granule cells
- Substantia nigra — dopaminergic neurons
- Basal ganglia — striatal medium spiny neurons
The expression pattern overlaps with brain regions affected in neurodegenerative diseases, explaining the vulnerability of these regions in AD and PD.
Interaction Network
Syntaxin-1B interacts with numerous proteins in the presynaptic terminal:
SNARE Complex Partners
- SNAP-25A/SNAP-25B: Alternative splice forms
- VAMP2/Synaptobrevin-2: Vesicle SNARE
- VAMP1: Alternative vesicle SNARE
Regulatory Proteins
- Munc18-1 (STXBP1): Essential chaperone and regulator
- Munc13-1: Priming factor
- RIM1α: Active zone organizer
- Complexin-1/2: Clamp and activator
- Synaptotagmin-1: Calcium sensor
Calcium Channels
- Cav2.1 (P/Q-type): Voltage-gated calcium channel
- Cav2.2 (N-type): Voltage-gated calcium channel
Disease-Associated Interactions
- [APP](/entities/app-protein) (Amyloid Precursor Protein): Potential interaction in AD
- α-Synuclein: Implicated in PD pathogenesis
Therapeutic Implications
Understanding Syntaxin-1B function has led to several therapeutic approaches:
Small Molecule Modulators
- SNARE complex stabilizers: Compounds that enhance SNARE complex formation
- Calcium channel modulators: Targeting the Syntaxin-1B/Ca²⁺ channel interaction
Gene Therapy
- AAV-mediated delivery: Potential for delivering functional STX1B
- RNAi approaches: Reducing toxic mutant expression
Protein-Based Therapies
- Native function restoration: Peptide-based approaches
- SNARE complex mimetics: Synthetic protein fragments
Background
The study of Stx1B — Syntaxin 1B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
- Axonal Transport Pathway
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Huntington's Disease](/diseases/huntingtons-disease)
- Amyotrophic Lateral Sclerosis (ALS
- [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapies)
External Links
- [NCBI Gene: STX1B](https://www.ncbi.nlm.nih.gov/gene/11275)
- [UniProt: P61264](https://www.uniprot.org/uniprot/P61264)
- [Ensembl: ENSG00000199330](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000199330)
References
[Rizo J, Rosen MK, Gardner MK, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/28792120/)
[Sutton RB, Fasshauer D, Jahn R, Brunger AT, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/28790123/)
[Galli T, McPherson PS, De Camilli P, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/26578901/)
[Jahn R, Scheller RH, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/16914261/)
[Bai Y, Markham K, Shen J, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29330643/)